Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01199042 · ClinicalTrials.gov registry record · NA
Bipap Automatic Servo Ventilation (autoSV) Advanced in Central Apnea Patients
A NA study, sponsored by Philips Respironics.
- Completed
- Registry status
- NA
- Development phase
- 29
- Enrollment target
NCT01199042 is a NA study that has completed, run by Philips Respironics. The registered enrollment target is 29 participants.
The verdict
NCT01199042, a NA study, has completed, sponsored by Philips Respironics.
- COMPLETED
- Registry status
- NA
- Development phase
- 29 participants
- Enrollment target
Study Summary
Pilot study testing the Bipap autoSV Advanced Algorithm during full night, in-lab polysomnography (PSG) and 3 months at home on patients with Central Sleep Apnea, Hunter Cheyne Stokes Respiration, or Complex Sleep Apnea.
Interventions
- DEVICE BiPAP autoSV Advanced
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 29 participants |
| Start Date | 2010-09 |
| Est. Completion | 2013-05 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01199042
The ClinicalTrials.gov registry entry for NCT01199042 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 29 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Philips Respironics, which has 35 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which BiPAP autoSV Advanced is the first listed.
NCT01199042 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01199042 about?
NCT01199042 is a clinical study titled "Bipap Automatic Servo Ventilation (autoSV) Advanced in Central Apnea Patients". Pilot study testing the Bipap autoSV Advanced Algorithm during full night, in-lab polysomnography (PSG) and 3 months at home on patients with Central Sleep Apnea, Hunter Cheyne Stokes Respiration, or Complex Sleep Apnea.
What is the current status of trial NCT01199042?
This trial is currently completed. It is a NA study. The enrollment target is 29 participants. The study started on 2010-09. Estimated completion is 2013-05.
What interventions are being tested in trial NCT01199042?
The interventions under investigation include: BiPAP autoSV Advanced (DEVICE).
Who is sponsoring clinical trial NCT01199042?
This trial is sponsored by Philips Respironics, which has 35 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.